000 01389 a2200409 4500
005 20250515045604.0
264 0 _c20070524
008 200705s 0 0 eng d
022 _a1538-4047
024 7 _a10.4161/cbt.5.12.3351
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Jun
245 0 0 _aAltered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells.
_h[electronic resource]
260 _bCancer biology & therapy
_cDec 2006
300 _a1632-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlternative Splicing
650 0 4 _aCell Line, Tumor
650 0 4 _aCisplatin
_xpharmacology
650 0 4 _aFanconi Anemia
_xcomplications
650 0 4 _aFanconi Anemia Complementation Group L Protein
_xgenetics
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGenes, BRCA1
650 0 4 _aGenes, BRCA2
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
650 0 4 _aMitomycin
_xpharmacology
650 0 4 _aPlasmids
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTransfection
700 1 _aWang, Xianshu
700 1 _aLin, Chia-Ju
700 1 _aCouch, Fergus J
700 1 _aFei, Peiwen
773 0 _tCancer biology & therapy
_gvol. 5
_gno. 12
_gp. 1632-6
856 4 0 _uhttps://doi.org/10.4161/cbt.5.12.3351
_zAvailable from publisher's website
999 _c16678437
_d16678437